#2571621
pataigin a bhfuil bagairt mhór i gceist léi (in-tarchurthacht agus déine);
high-threat pathogen (transmissibility and severity);
pataigin a bhfuil bagairt mhór i gceist léi (in-tarchurthacht agus déine);
high-threat pathogen (transmissibility and severity);
díghalrú gnáthaimh: Díghalrú ar dhromchlaí a d’fhéadfadh siad a bheith éillithe le pataigin le linn próisis liachta nó altra ar bhonn rialta chun riosca tógála a laghdú d’orgánaigh mar sin trí dhromchlaí.
Routine disinfection: Disinfection of surfaces, which might be contaminated with pathogens during medical or nursing processes, on a regular basis to reduce the risk of transmission of such organisms via surfaces.
díghalrú gnáthaimh: Díghalrú ar dhromchlaí, a d’fhéadfadh siad a bheith éillithe le pataigin le linn próisis liachta nó altra ar bhonn rialta chun riosca tógála a laghdú d’orgánaigh mar sin trí dhromchlaí.
Routine disinfection: Disinfection of surfaces, which might be contaminated with pathogens during medical or nursing processes on a regular basis to reduce the risk of transmission of such organisms via surfaces.
díghalrú gnáthaimh: Díghalrú ar dhromchlaí a d’fhéadfadh siad a bheith éillithe le pataigin le linn próisis liachta nó altra ar bhonn rialta chun riosca tógála a laghdú d’orgánaigh mar sin trí dhromchlaí.
Routine disinfection: Disinfection of surfaces which might be contaminated with pathogens during medical or nursing processes, on a regular basis, to reduce the risk of transmission of such organisms via surfaces.
díghalrú gnáthaimh: Díghalrú ar dhromchlaí a d’fhéadfadh siad a bheith éillithe le pataigin le linn próisis liachta nó altra ar bhonn rialta chun riosca tógála a laghdú d’orgánaigh mar sin trí dhromchlaí.
Routine disinfection: Disinfection of surfaces which might be contaminated with pathogens during medical or nursing processes, on a regular basis to reduce the risk of transmission of such organisms via surfaces.
An bhfuil an acmhainneacht ag do Bhallstát pataigin nua a thréithriú le Seicheamhú den Chéad Ghlúin Eile (NGS)?
Does your Member State have the capacity for characterization of a novel pathogen by Next Generation Sequencing (NGS)?
Déanfar staidéir ábhartha ar éifeachtaí pataigineacha/ionfhabhtaíocha ar algaí agus ar an ráta fáis más eol go bhfuil modh gníomhaíochta luibhicídeach ag an miocrorgánach nó más eol go bhfuil dlúthbhaint aige le pataigin planda, mura léiríonn an t-iarratasóir, trí chur chuige thromachar na fianaise, ceann de na cásanna seo a leanas:
Relevant studies on pathogenic/infective effects on algae growth and growth rate shall be performed if the micro-organism is known to have an herbicidal mode of action or to be closely related to a plant pathogen, unless the applicant demonstrates, by following a weight of evidence approach, that:
Déanfar staidéir ábhartha ar éifeachtaí pataigineacha/ionfhabhtaíocha ar mhacraifítí uisceacha más eol go bhfuil modh gníomhaíochta luibhicídeach ag an miocrorgánach nó más eol go bhfuil dlúthbhaint aige le pataigin planda, mura léiríonn an t-iarratasóir, trí chur chuige thromachar na fianaise, ceann de na cásanna seo a leanas:
Relevant studies on pathogenic/infective effects on aquatic macrophytes shall be performed if the micro-organism is known to have an herbicidal mode of action, or to be closely related to a plant pathogen, unless the applicant demonstrates, by following a weight of evidence approach, that:
Déanfar staidéir ábhartha ar éifeachtaí pataigineacha/ionfhabhtaíocha ar phlandaí talún nach spriocphlandaí talún iad más eol go bhfuil modh gníomhaíochta luibhicídeach ag an miocrorgánach nó más eol go bhfuil dlúthbhaint aige le pataigin planda, mura léiríonn an t-iarratasóir, trí chur chuige thromachar na fianaise, ceann de na cásanna seo a leanas:
Relevant studies on pathogenic/infective effects on non-target terrestrial plants shall be performed if the micro-organism is known to have an herbicidal mode of action or to be closely related to a plant pathogen, unless the applicant demonstrates, by following a weight of evidence approach, that:
Má tá modh gníomhaíochta luibhicídeach ag an miocrorgánach nó má tá dlúthbhaint aige le pataigin is eol a bheith ann, agus má tá an fhéidearthacht ann go nochtfaí plandaí talún ar an miocrorgánach de réir an bhreithnithe a rinneadh faoi phointe 1.6, ní dheonófar aon údarú má tá an miocrorgánach pataigineach do phlandaí talún nó má tá éifeachtaí tocsaineacha ag an táirge cosanta plandaí ar phlandaí talún.
If the micro-organism has an herbicidal mode of action or it is closely related to a known plant pathogen, and there is a possibility of terrestrial plants being exposed to the micro-organism according to the consideration done under point 1.6, no authorisation shall be granted if the micro-organism is pathogenic to, or the plant protection product has toxic effects on, terrestrial plants.
Is pataigin Staphylococcus aureus frithsheasmhach in aghaidh meiticilline (MRSA) atá ina chúis le go leor ionfhabhtuithe a bhaineann leis an bpobal agus le cúram sláinte agus atá deacair a chóireáil i ndaoine daonna mar tá na hionfhabhtuithe sin frithsheasmhach in aghaidh antaibheathaigh iomadúla.
Methicillin-resistant Staphylococcus aureus (MRSA) is a pathogen that causes many healthcare- and community-associated infections that are difficult to treat in humans as they are resistant to multiple antibiotics.
Commodity risk assessment of oak logs with bark from the US for the oak wilt pathogen Bretziella fagacearum under an integrated systems approach [Measúnú riosca tráchtearraí ar lomáin darach a bhfuil an choirt orthu maidir le pataigin an tsleabhctha darach Bretziella fagacearum faoi chur chuige córas comhtháthaithe].
Commodity risk assessment of oak logs with bark from the US for the oak wilt pathogen Bretziella fagacearum under an integrated systems approach.
Sonraigh leibhéal comhfhreagrach do Bhallstáit maidir le tástálacha nua bunaithe ar aimpliúchán aigéid núicléasaigh (NAATanna) agus córais saotharlainne oiriúnaithe ghaolmhara a chur chun feidhme i gcás ina dtiocfaidh pataigin nua chun cinn lena mbaineann an fhéidearthacht go gcruthófaí paindéim mar thoradh uirthi:
Please indicate your Member State’s corresponding level regarding implementation of new nucleic acid amplification-based tests (NAATs) and adapted associated laboratory systems in the event of a novel pathogen emergence with pandemic potential: